CFB
ROIV icon

Cullen/Frost Bankers’s Roivant Sciences ROIV Stock Holding History

Cullen/Frost Bankers’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Sell
3,868
-1
-0% -$30 ﹤0.01% 661
2026
Q1 		$107K Sell
3,869
-831
-18% -$21.3K ﹤0.01% 661
2025
Q4 		$102K Hold
4,700
– – ﹤0.01% 679
2025
Q3 		$71.1K Hold
4,700
– – ﹤0.01% 693
2025
Q2 		$53K Hold
4,700
– – ﹤0.01% 746
2025
Q1 		$47.4K Sell
4,700
-3,600
-43% -$38.9K ﹤0.01% 728
2024
Q4 		$98.2K Hold
8,300
– – ﹤0.01% 602
2024
Q3 		$95.8K Hold
8,300
– – ﹤0.01% 617
2024
Q2 		$87.7K Hold
8,300
– – ﹤0.01% 608
2024
Q1 		$87.5K Buy
+8,300
New +$89.5K ﹤0.01% 583

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Cullen/Frost Bankers's ROIV Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Roivant Sciences (ROIV) stake by 0.03% in Q2 2026, selling an estimated $30 and leaving 3,868 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #661.

Cullen/Frost Bankers first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Cullen/Frost Bankers held 3,868 shares of Roivant Sciences worth $137K as of Q2 2026.
  • Cullen/Frost Bankers sold 1 Roivant Sciences share in Q2 2026, an estimated $30.
  • Roivant Sciences made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #661 holding.
  • Cullen/Frost Bankers first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.